Caixin Global – Latest China News & Headlines

Home >


CX Tech is Caixin Global's real-time tech news portal, featuring 24-hour news, short-form analysis, and roundups from business and tech media in China.

Trending in China – Clothing Company Picks Fight With Shaolin Kung Fu Monastery
Trending in China: Medical Drama Salutes Pandemic Heroes but Stirs Sexism Debate
Trending in China – Can Universities Stop Students Wasting Food And Keep Them Happy?
Alibaba Unveils Delivery Robot to Meet ‘Last-Mile’ Demand
Alibaba Launches Palm-Sized Cloud Computer With ‘Almost Unlimited Computing Resources’
China’s National Science Academy Vows to Close Tech Gaps in 10 Years
Trump’s WeChat Ban May Face Temporary Halt by U.S. Judge
Tencent Clinches Deal to Show England’s Premier League in China
Alibaba Unveils ‘Digital Factory’ as Part of Its ‘New Manufacturing’ Strategy
Trending in China: Basketballer Jeremy Lin - Dream Chaser or Delusional? Netizens Divided as Star Leaves CBA for NBA
Trending in China – The Case of the ‘Missing’ iPhone12
Kuaishou Logs 500 Million Online Shopping Orders in August
U.S.-Listed Chinese Delivery Firm ZTO Express Plans to Raise Up to $1.6 Billion in Hong Kong Secondary Listing
Xiaomi Vice Chairman Promises Not Sell More Stock After Selling Over $1 Billion in Company Shares
Autohome Plans $1 Billion Hong Kong Second Listing
Video Streamer iQiyi Kicks Up Its Sports Game with FC Barcelona Tie-Up
Global First as Potential Nasal Spray Covid-19 Vaccine Proceeds to Clinical Trial Phase’s Fintech Unit Plans to Spend $230 Million to Get Second Payment License
Trending in China – A Fight Over Steamed Buns Causes Netizens to Ask Whether Traditional Brands Can Survive in the Modern Era
Loss Making Evergrande’s Electric Vehicle Subsidiary to Raise $516 Million from Investors Including Tencent
BGI Genomics to Invest in Qingdao Medical Park

By Tang Ziyi / Jun 26, 2019 06:08 PM / Business & Tech

Photo: IC Photo

Photo: IC Photo

Chinese genomics giant BGI Genomics will spend 470 million yuan ($68.3 million) on establishing an industrial park in the eastern port city of Qingdao, Shandong province, the company said Tuesday.

The planned medical park will focus on researching and developing tests for conditions including congenital diseases and tumors, according to the statement.

The Qingdao medical park is the latest in a wave of genetics industrial parks that are sweeping China, as the country hopes to dominate the burgeoning industry. The controversial announcement last year that the world’s first genetically altered babies had been born in China drew attention to the southern Chinese city of Shenzhen, where the scientist who claimed to have altered the babies’ DNA — He Jiankui — had worked. Shenzhen is home to two of China’s biggest genetics industrial parks, including one jointly financed by BGI.

Related: Genome Sequencing Giant BGI's Fundraising Flops

A previous version of this story inaccurately described He Jiankui's connection to a BGI-funded park in Shenzhen.

Contact reporter Tang Ziyi (

Share this article
Open WeChat and scan the QR code